Dihexa is a peptide-derived oligomer developed for preclinical research into synaptogenesis and hepatocyte growth factor (HGF) signaling pathways. PX1 Research supplies research-grade Dihexa verified by HPLC/MS and endotoxin analysis, featuring domestic USA synthesis, lot-specific COAs, and same-day dispatch from our California and Arizona logistics facilities.
Dihexa is a peptide-derived oligomer developed for preclinical research into synaptogenesis and hepatocyte growth factor (HGF) signaling pathways. PX1 Research supplies research-grade Dihexa verified by HPLC/MS and endotoxin analysis, featuring domestic USA synthesis, lot-specific COAs, and same-day dispatch from our California and Arizona logistics facilities.
Dihexa (N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide) is an oligopeptide derivative engineered to bind with high affinity to hepatocyte growth factor (HGF) and its receptor, c-Met. Developed in academic laboratory settings to evaluate neuroplasticity and dendritic spine formation, it serves as a core tool in molecular neuroscience and cell biology experiments.
In vitro and animal models show that Dihexa potentiates HGF/c-Met signaling at picomolar concentrations, facilitating synaptogenic pathways and structural cellular assembly. It is strictly designated for laboratory research and in vitro investigations, requiring rigorous analytical verification prior to assay integration.
Researchers evaluating high-purity compounds can review verified batches directly through our Dihexa product page or explore our broader catalog of research peptides for comparative assay development.
Dihexa is an orally active, lipophilic peptide analog structurally derived from angiotensin IV. Unlike native angiotensin peptides, which possess limited metabolic stability and short biological half-lives, Dihexa was intentionally designed with structural modifications—specifically an N-terminal hexanoyl group—to improve stability against enzymatic degradation in laboratory models.
Chemical characterization reveals a low molecular weight oligomer capable of crossing hydrophobic lipid barriers in cellular models. This structural modification allows researchers to examine long-term receptor interaction kinetics without rapid peptide cleavage, providing a consistent baseline during extended cell culture assays.
Investigators interested in detailed chemical sequencing, molecular weights, and analytical parameters can consult our dedicated Dihexa research guide for comprehensive structural breakdowns.
The primary mechanism of Dihexa revolves around its interaction with the Hepatocyte Growth Factor (HGF) system. In baseline physiological systems, HGF binds to the c-Met receptor tyrosine kinase, initiating intracellular signaling cascades responsible for cell survival, tissue remodeling, and synaptic connectivity.
Preclinical data indicate that Dihexa acts as a potent HGF mimetic and potentiator. Upon binding to HGF, it induces receptor dimerization and phosphorylation of c-Met, subsequently activating key downstream pathways including the PI3K/Akt and MAPK/ERK cascades. These pathways regulate structural synaptic plasticity, including the growth of spinophilin-positive dendritic spines.
Crucially, in vitro assays demonstrate that Dihexa exhibits activity at picomolar concentrations, making it several orders of magnitude more potent than native HGF in stimulating dendritic arborization. This heightened receptor sensitivity makes it a primary focus for researchers studying neuroplasticity and synaptogenesis mechanisms.
In neuroscience and cellular signaling studies, researchers often evaluate Dihexa alongside other signaling compounds to compare pathway activation. While Dihexa targets HGF/c-Met pathways, peptides such as Semax interact primarily with brain-derived neurotrophic factor (BDNF) and melanocortin receptor systems.
Similarly, Selank is studied for its modulation of GABAergic transmission and enkephalin stability rather than direct receptor dimerization. Dihexa remains unique due to its specific structural binding to HGF, providing a distinct mechanism for cellular models focused on structural synaptogenesis.
For multi-compound comparative studies, investigators can review our full inventory across the PX1 catalog to source standardized, high-purity compounds for parallel experimentation.
In vitro research using primary neuronal cultures has evaluated Dihexa's capacity to induce spinogenesis and synaptogenesis. Quantitative immunohistochemistry in these models demonstrates increased dendritic spine density and spinophilin immunoreactivity following incubation with Dihexa solutions.
In rodent models of cognitive impairment and neurodegeneration, researchers have utilized Dihexa to observe functional spatial learning and memory metrics using tests such as the Morris Water Maze. These studies aim to map how HGF/c-Met activation impacts functional neural architecture following chemical or physical lesioning.
Furthermore, ongoing preclinical research investigates Dihexa's role in cellular repair models outside the central nervous system, including liver regeneration and muscular tissue repair assays where HGF signaling pathways are heavily implicated.
Procuring research compounds requires strict adherence to quality control metrics. Laboratories frequently encounter compromised data due to sub-standard chemical sourcing. Key red flags to avoid include:
1. Absence of Lot-Specific COAs: Vendors supplying static or outdated Certificates of Analysis without matching lot numbers cannot guarantee current purity or identity.
2. Missing Endotoxin Screening: For cell culture applications, unverified endotoxin levels can induce cellular toxicity and falsify experimental outcomes.
3. Vendor Claims of Human Use: Any supplier promoting human dosing, clinical efficacy, or personal administration violates regulatory standards and lacks legitimate research-grade verification.
4. Non-Standardized Storage/Shipping: Uncontrolled thermal management during transit can cause structural degradation of sensitive peptide bonds.
When auditing vendors for laboratory procurement, research managers should evaluate prospective suppliers against standardized analytical criteria:
• Purity Verification: Every batch must undergo High-Performance Liquid Chromatography (HPLC) showing ≥98% purity, alongside Mass Spectrometry (MS) to confirm molecular weight.
• Sourcing & Synthesis: USA-based synthesis facilities operating under strict Quality Management Systems eliminate cross-contamination risks.
• Lot Traceability: Complete tracking from raw synthesis material to finished container ensures batch-to-batch consistency across longitudinal studies.
• Endotoxin Testing: Chromogenic LAL assays must verify endotoxin levels below actionable thresholds (<0.05 EU/mg) for cellular compatibility.
• Shipping Speed & Handling: Domestic dispatch with ambient thermal protection prevents environmental degradation during transit.
• Technical Support: Direct access to analytical data and responsive customer support ensures rapid resolution of technical inquiries.
Dihexa exhibits hydrophobic characteristics due to its N-terminal modification. When preparing stock solutions for laboratory assays, researchers typically utilize organic solvents such as dimethyl sulfoxide (DMSO) or ethanol before dilution into aqueous buffers like phosphate-buffered saline (PBS).
Stock solutions should be aliquoted and stored at -20°C or -80°C to maintain stability over extended research timelines, avoiding repeated freeze-thaw cycles that could induce molecular degradation.
To review technical specifications, physical properties, and research formats, visit the Dihexa 10mg catalog page or consult our analytical resources in the PX1 Research Library.
PX1 Research provides high-purity Dihexa specifically manufactured for laboratory research use only. Every shipment includes lot-matched Certificates of Analysis verifying HPLC purity, identity via mass spectrometry, and endotoxin compliance.
Orders placed before 12:00 PM PST Monday through Friday dispatch same-day from our dual California and Arizona distribution centers. We offer tracked domestic transit to ensure swift delivery and minimal thermal exposure for your laboratory supplies.
Whether your research protocol requires standardized 10 mg formats or bulk institutional quantities, our team is equipped to support your procurement needs. Explore our bulk options through our wholesale peptide supply portal or directly order 10 mg Dihexa formats today.
What is Dihexa used for in research?
Dihexa is a research peptide studied in preclinical models for its role as a hepatocyte growth factor (HGF) potentiator. Researchers use it to investigate synaptogenesis, dendritic spine growth, and c-Met receptor pathway activation in cell cultures and animal models.
Is Dihexa legal to buy in the US for research?
Yes, Dihexa is legal to purchase in the United States as a research chemical intended strictly for in vitro laboratory and preclinical experimental use. It is not approved for human consumption or clinical therapeutic applications.
How fast does PX1 Research ship Dihexa orders?
Orders placed before 12:00 PM PST Monday through Friday ship the same day from our logistics hubs in California and Arizona. Fast, tracked domestic shipping ensures prompt delivery to your research facility.
Do you provide a COA for my Dihexa lot?
Yes. Every batch of Dihexa from PX1 Research includes a lot-specific Certificate of Analysis detailing HPLC purity levels, mass spectrometry identity confirmation, and endotoxin test results.
What purity level is guaranteed for PX1 Research Dihexa?
PX1 Research guarantees a minimum purity of 98% for all Dihexa lots, verified through independent high-performance liquid chromatography (HPLC) testing prior to distribution.
What formats is Dihexa supplied in by PX1 Research?
PX1 Research supplies Dihexa in precise research-grade formats, including 10 mg units designed for standardized analytical and in vitro assay preparations.
How should Dihexa be stored upon delivery?
Dihexa should be stored in a cool, dry place away from direct light upon receipt. For long-term stability, lyophylized powders or dissolved stock solutions should be kept at -20°C or lower.
Is Dihexa approved for human consumption or clinical use?
No. Dihexa is an unapproved research compound strictly intended for laboratory experimentation and preclinical study. It must never be administered to humans or animals outside of approved research protocols.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.